内镜下逆行胰胆管造影置放胆道支架治疗恶性梗阻性黄疸98例疗效分析

来源 :现代生物医学进展 | 被引量 : 0次 | 上传用户:n0131
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨内镜下逆行胰胆管造影置放胆道支架对恶性胆道梗阻的疗效及并发症的防治。方法:选择2008年2月至2011年9月我院收治的无法手术切除或不愿手术的恶性胆道梗阻患者98例,通过放置内置支架引流观察其操作成功率、支架通畅期和退黄效果、并发症发生情况及其防治效果和患者生存期等。结果:98例患者中有88例成功通过置入胆道内置引流管,成功率为89.8%,并发症发生率为11.22%,所有成功患者术后1周黄疸明显减退,支架平均通畅期137天,患者平均生存期为163天。结论:行胆道内置支架引流创伤小,并发症少,通畅性能好,可持久有效地控制黄疸,有效缓解病情,改善全身情况,明显延长恶性胆道梗阻患者的生存期。 Objective: To investigate the efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in the placement of biliary stents on malignant biliary obstruction and the prevention and treatment of complications. Methods: From February 2008 to September 2011, 98 cases of malignant biliary obstruction who can not be surgically removed or unwilling to be surgically treated in our hospital were selected. The operation success rate, stent unobstructed period, Complications and its prevention and treatment and patient survival and so on. Results: Among the 98 patients, 88 cases successfully passed the built-in biliary drainage tube, the success rate was 89.8% and the complication rate was 11.22%. All the successful patients had a significant decrease of jaundice one week after operation, with an average of 137 days of stent open- The average survival of patients was 163 days. CONCLUSION: The biliary tracheal stent drainage is less invasive and has fewer complications and good patency. It can control jaundice effectively and effectively for a long time, effectively relieve the condition and improve the general condition, and prolong the survival of patients with malignant biliary obstruction.
其他文献
本文综述等离子显示器件几年来疾速发展的成果,指出它的特点,并分别描述它的各类型屏面的作用原理和现有水平,特别注意关于屏面结构、工艺、材料等方面的问题。 This paper
目的:探讨代表不同耐药机制的P糖蛋白(P-gp)、谷胱甘肽S-转移酶(GST-π)、DNA拓扑异构酶Ⅱ(TopoⅡ)、胸苷酸合成酶(TS)在原发宫颈鳞癌组织中的表达及其与临床病理参数的关系;
社会在进步,时代在发展,教育也在发生翻天覆地的变化,中学体育教师应该具备的素质也在不断的发生变化.本文就中学体育教师的基本素质谈一些自己的看法,为造就和培养适应社会
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
期刊